July 26, 2019 – “Blockchains for secure digitized medicine”. This is the title of a very interesting and important article in the Journal of Personalised Medine (JPM) as of May 28, 2019. Blockchain as an emerging technology (particularly around the hype …

The phenotype broker: Blockchain and patient phenotype Read more »

Tagged with: , , , , , , , , , , , , , , , , ,

March 31, 2018 – Are patients ready for direct-to-consumer genetic testing?  This was the very important and central question that came up in the article by Matt Smith on Medscape, published March 29, 2018. Since thasso is all about theragenomic …

Direct-to-Consumer Genetic Testing: Are Patients Ready? Read more »

Tagged with: , , , , , ,

July 9, 2016 – This is a huge step into the future of theragenomic and personalized medicine and individualized drug safety. In support of the President’s Precision Medicine Initiative (PMI), the American Food & Drug Administration (FDA) just issued two …

Precision Medicine Initiative: draft guidances issued Read more »

Tagged with: , , , , , , ,

February 8, 2015 – The American Food and Drug Administration (FDA) has granted accelerated approval to Palbociclib (Ibrance) to treat advanced (metastatic) breast cancer.  The FDA granted Ibrance breakthrough therapy designation because the sponsor demonstrated through preliminary clinical evidence that the …

Theragenomic Medicine: Palbociclib (Ibrance) approved for postmenopausal women with advanced (metastatic) breast cancer Read more »

Tagged with: , , , , , ,

July 01, 2014 – As the knowledge of genetics and genomics rapidly expand, a personalized approach to health care is becoming increasingly important. India is fast becoming a promising contender in the global healthcare arena The majority of the global …

India steps closer to Personalized Medicine Read more »

Tagged with: , , ,

June 22, 2014 – The individuum (i.e., patient) is the phenotype expert on her/his individualized form of proper disease she/he is suffering from. It is not her/his treating physician, it is not a regulatory person concerned with the safety and …

The Apomediary [Patient Expert] and Personalized Medicine: A Commentary Read more »

Tagged with: , , , , , , , , , , , , , ,

Apple has unveiled HealthKit, a platform to centralise data from different types of devices, like fitness trackers, heart rate and blood pressure monitors. Launching iOS 8 for iPhones and iPads, which it describes as the biggest release since the launch …

Apple plan to revolutionize mobile healthcare: Personalized medicine at the horizon on the iPhone and the likes Read more »

Tagged with: , , ,

April 23, 2014 – The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes). MCD causes an abnormal overgrowth of immune …

FDA approves Siltuximab [Sylvant] for rare Castleman’s disease Read more »

Tagged with: , , , , , , ,

October 10, 2013 – Very recently, David Kerr, Professor of Cancer Medicine at University of Oxford, in the United Kingdom, and past President of the European Society for Medical Oncology, talked on Medscape (see the video here) about risk-benefit analyses …

Can We Identify Risk for Drug Toxicity? Read more »

Tagged with: , , , , , , , , , , , , ,

January 26, 2012 – I am relaying the information below by the EMA to the readers of this blog. It might be interessting to dwell into this concept paper (as a scientist, a treating physician, or an informed patient) for informations only or even …

EMA: Public consultation open on concept paper on pharmacogenomics in evaluation of authorised medicines Read more »

Tagged with: , , , , ,